Letter: Mendelian randomization--New perspective in inflammatory bowel disease and pancreatic cancer?

被引：3
|
作者：
Min, Yu [1 ,2 ]
Wei, Xiaoyuan [3 ,4 ,5 ]
Peng, Xingchen [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp, Canc Ctr, Dept Biotherapy, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Canc Ctr, Sichuan, Peoples R China
[3] Sichuan Univ, Dept Head & Neck Oncol, Sichuan, Peoples R China
[4] Sichuan Univ, West China Hosp, Dept Head & Neck Oncol, Sichuan, Peoples R China
[5] Sichuan Univ, West China Hosp, Canc Ctr, Dept Radiat Oncol, Sichuan, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 58卷 / 01期
基金：
中国国家自然科学基金;
关键词：
RISK;
D O I：
10.1111/apt.17537
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Massironi et al papers. To view these articles, visit and
引用
收藏
页码：143 / 144
页数：2
相关论文
共 50 条
  • [1] Letter: Mendelian randomization --new perspective in inflammatory bowel disease and pancreatic cancer? Authors' reply
    Massironi, Sara
    Vigano, Chiara
    Danese, Silvio
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (01) : 145 - 146
  • [2] Inflammatory Bowel disease promote oral cancer and pharyngeal cancer: new evidence of Mendelian randomization
    Chen, Gui
    Xie, Junyang
    Liang, Tianhao
    Wang, Yiyan
    Liao, Wenjing
    Song, Lijuan
    Zhang, Xiaowen
    ACTA OTO-LARYNGOLOGICA, 2022, 142 (02) : 191 - 196
  • [3] Keratoconus and inflammatory bowel disease: mendelian randomization
    Jin, Yiheng
    Wang, Yuanfeng
    Qiu, Xu
    Liu, Jiao
    Qu, Shugen
    FRONTIERS IN GENETICS, 2024, 15
  • [4] Graves Disease and Inflammatory Bowel Disease: A Bidirectional Mendelian Randomization
    Xian, Wei
    Wu, Dide
    Liu, Boyuan
    Hong, Shubin
    Huo, Zijun
    Xiao, Haipeng
    Li, Yanbing
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (05): : 1075 - 1083
  • [5] Inflammatory bowel disease and bladder cancer risk: based on a Mendelian randomization study
    Li Wang
    Jing-ya Deng
    Kun-peng Li
    Ping-yu Shan-Yin
    BMC Urology, 23
  • [6] Inflammatory bowel disease and bladder cancer risk: based on a Mendelian randomization study
    Wang, Li
    Deng, Jing-ya
    Li, Kun-peng
    Zhu, Ping-yu
    BMC UROLOGY, 2023, 23 (01)
  • [7] Associations of inflammatory cytokines with inflammatory bowel disease: a Mendelian randomization study
    Song, Zhaoxiang
    Li, Xiangyu
    Xie, Jinlin
    Han, Fei
    Wang, Nan
    Hou, Yuhan
    Yao, Jianning
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [8] Association between inflammatory bowel disease and pancreatic cancer: results from the two-sample Mendelian randomization study
    Min, Yu
    Liu, Zheran
    Li, Ruidan
    Jin, Jing
    Wei, Zhigong
    Pei, Yiyan
    Hu, Xiaolin
    Peng, Xingchen
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Platelet indices and inflammatory bowel disease: a Mendelian randomization study
    Li, Hong-yang
    Liu, Tie-mei
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [10] Atopic disease and inflammatory bowel disease: A bidirectional Mendelian randomization study
    Zheng, Dongyuan
    Xu, Qinke
    Liu, Yingchao
    MEDICINE, 2024, 103 (42)
12345